Physician profile
Michael Gallo
NPI 1861856510
$1,835.93
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.00 · 2020: $23.18 · 2021: $14.05 · 2022: $207 · 2023: $1,041 · 2024: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,433 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,432.60 |
| Education | $129.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $334.64 | 2023-2024 | Wakix |
| Itamar Medical INC | $236.09 | 2023-2024 | Watchpatone |
| Jazz Pharmaceuticals INC. | $231.42 | 2023-2024 | Xywav |
| Medtronic, INC. | $174.06 | 2022 | |
| Novo Nordisk INC | $173.34 | 2022-2023 | Wegovy, Ozempic, Rybelsus |
| Axsome Therapeutics, INC. | $152.97 | 2023-2024 | Sunosi |
| Abbott Laboratories | $134.14 | 2023 | Mitraclip |
| Idorsia Pharmaceuticals US INC | $121.87 | 2024 | Quviviq |
| Zoll Respicardia, INC. | $80.56 | 2023 | Remede System |
| Pfizer INC. | $44.31 | 2023-2024 | |
| Samsung Hme America, INC. | $30.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.76 | 2023 | Jardiance |
| Fisher & Paykel Healthcare INC | $25.01 | 2024 | Fisher & Paykel Healthcare |
| Kerecis Limited | $23.18 | 2020 | |
| Amgen INC. | $16.31 | 2023 | Repatha |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.22 | 2023 | |
| Leo Pharma INC. | $14.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gallo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.